₹40,460 Cr
25.59
₹1,581 Cr
As on 13-Aug-2024 IST
₹-0.75
•
-0.22%
₹337.85
₹338.00
₹342.00
₹334.05
33,60,380
₹217.50 - 376.80
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Biocon
| 35.03 | -3.89 | 10.89 | 31.58 | -3.44 | 8.05 | 15.84 |
|
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
BSE Mid Cap
| 26.89 | -1.61 | 13.94 | 53.62 | 26.75 | 27.88 | 17.84 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Biocon
| -4.66 | -28.19 | -21.71 | 58.00 | -6.14 | 16.92 | 69.70 |
|
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Biocon Ltd stood at ₹ 56,071 Cr as on 30-Jun-24
The share price of Biocon Ltd is ₹337.10 (NSE) and ₹337.00 (BSE) as of 13-Aug-2024 IST. Biocon Ltd has given a return of -3.44% in the last 3 years.
Biocon Ltd has a market capitalisation of ₹ 40,460 Cr as on 13-Aug-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Biocon Ltd is 1.99 times as on 13-Aug-2024, a 67% discount to its peers’ median range of 6.09 times.
The P/E ratio of Biocon Ltd is 25.59 times as on 13-Aug-2024, a 40% discount to its peers’ median range of 42.30 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Biocon Ltd and enter the required number of quantities and click on buy to purchase the shares of Biocon Ltd.
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, the company is involved in the integrated discovery, development, and manufacturing services for small and large molecules. It serves customers in approximately 120 countries. The company was incorporated in 1978 and is headquartered in Bengaluru, India.
The promoters of Biocon Ltd are KIRAN MAZUMDAR SHAW and GLENTEC INTERNATIONAL. They collectively own 60.12 per cent of the total equity. The chairman of the company is Kiran Mazumdar-Shaw
There is no promoter pledging in Biocon Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
57,836
|
|
|
48,762
|
|
|
37,484
|
|
|
34,612
|
| Biocon Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
8.06
|
|
Operating margin(%)
|
10.76
|
|
Net Margin(%)
|
12.37
|
|
Dividend yield(%)
|
0.15
|
Yes, TTM profit after tax of Biocon Ltd was ₹1,581 Cr.
₹40,460.22 Cr
₹14,766.00 Cr
₹1,580.80 Cr
₹2,574.30 Cr
₹15,729.60 Cr
60.64%
High
₹217.50 - 376.80
₹5.00
1,20,06,00,000
NSE: BIOCON, BSE: 532523
Bengaluru, Karnataka
www.biocon.com
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of... diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, the company is involved in the integrated discovery, development, and manufacturing services for small and large molecules. It serves customers in approximately 120 countries. The company was incorporated in 1978 and is headquartered in Bengaluru, India. Read more
Stocks 
Biocon Ltd.
Widely used:
